- Trials with a EudraCT protocol (77)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
77 result(s) found for: Left bundle branch block.
Displaying page 1 of 4.
| EudraCT Number: 2006-000978-68 | Sponsor Protocol Number: | Start Date*: 2006-12-18 |
| Sponsor Name:AstraZeneca | ||
| Full Title: Treatment of systemic effects in patients with COPD | ||
| Medical condition: Chronic obstructive pulmonary disease (COPD) is a preventable and treatable disease state characterized by airflow limitation that is not fully reverible. The airflow limitation is usually progress... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2015-003895-65 | Sponsor Protocol Number: DAL-301 | Start Date*: 2016-06-22 | |||||||||||
| Sponsor Name:DalCor Pharma UK Ltd, Leatherhead, Swiss Branch Zug | |||||||||||||
| Full Title: A phase III, double-blind, randomized placebo-controlled study to evaluate the effects of dalcetrapib on cardiovascular (CV) risk in a genetically defined population with a recent Acute Coronary Sy... | |||||||||||||
| Medical condition: This study is investigating the cardiovascular morbidity and mortality (cardiovascular death, resuscitated cardiac arrest, non-fatal myocardial infarction (MI) and non-fatal stroke) in subjects wit... | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: NL (Completed) BE (Completed) SE (Completed) SK (Completed) DK (Completed) FI (Completed) PT (Completed) DE (Completed) HU (Completed) ES (Ongoing) AT (Completed) CZ (Completed) BG (Completed) RO (Ongoing) PL (Completed) GB (GB - no longer in EU/EEA) IT (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2013-002882-20 | Sponsor Protocol Number: 2013-03 | Start Date*: 2013-12-18 |
| Sponsor Name:Västra Götalands Center för utveckling av prehospital akutsjukvård | ||
| Full Title: DETermination of the role of OXygen in Acute Myocardial Infarction (DETO₂X-AMI) trial | ||
| Medical condition: Acute myocardial infarction | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: SE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2006-001704-37 | Sponsor Protocol Number: CSPP100A2340 | Start Date*: 2006-11-03 |
| Sponsor Name:Novartis Pharma Services AG | ||
| Full Title: A 36 week, multicenter, randomized, double-blind, placebo- controlled, parallel-group, pilot study to evaluate the efficacy and safety of aliskiren on the prevention of left ventricular remodeling ... | ||
| Medical condition: Hypertension | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Completed) DK (Completed) DE (Completed) SE (Completed) BE (Completed) CZ (Completed) HU (Completed) GB (Completed) SK (Completed) IT (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2021-001534-19 | Sponsor Protocol Number: APHP200015 | Start Date*: 2021-05-21 |
| Sponsor Name:AP-HP/DRCI | ||
| Full Title: Direct oral Anticoagulants for Prevention of lEft ventRIcular Thrombus after anterior acute myocardial InFarction | ||
| Medical condition: Left ventricular (LV) thrombus after acute myocardial infarction (AMI) | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: FR (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2014-005407-24 | Sponsor Protocol Number: KKIKEM | Start Date*: 2015-02-27 |
| Sponsor Name:IKEM | ||
| Full Title: Effect of early administration of eplerenone in patients after acute myocardial infarction | ||
| Medical condition: Verify the efficacy of early administration of eplerenone in relation to the development of pathological remodeling of the myocardium in patients after myocardial infarction. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: CZ (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2005-003638-17 | Sponsor Protocol Number: HEMOPURE II and/or COR-002 | Start Date*: 2005-10-28 |
| Sponsor Name:Biopure Corporation | ||
| Full Title: This is a phase II, open-label study in the catheterization laboratory setting to challenge the concept that HBOC-201 ® administration might improve myocardial ‘oxygenation’ and myocardial function... | ||
| Medical condition: Treatment of several ischemic conditions, such as acute coronary syndromes (ACS) | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2007-003941-34 | Sponsor Protocol Number: 22021980 | Start Date*: 2008-02-11 |
| Sponsor Name:Vorstand des Klinikums der Universität München - Grosshadern | ||
| Full Title: SAFETY AND EFFICACY OF SITAGLIPTIN PLUS GRANULOCYTE-COLONY STIMULATING FACTOR IN PATIENTS SUFFERING FROM ACUTE MYOCARDIAL INFARCTION - SITAGRAMI-Trial | ||
| Medical condition: Patients undergoing routine percutaneous coronary revascularisation for acute ST segment elevation myocardial infarction (STEMI, time from onset of infarction to intervention 2 to 24 hours) | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2018-000590-75 | Sponsor Protocol Number: betami_vs_1.0 | Start Date*: 2018-05-31 |
| Sponsor Name:Oslo University Hospital | ||
| Full Title: BEta-Blocker Treatment after Acute Myocardial Infarction in revascularized patients with preserved left ventricular systolic function (BETAMI trial) | ||
| Medical condition: Patients admitted to hospital with acute myocardial infarction treated With reperfusion therapy (i.e trombolysis or percutaneous coronary intervention) | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NO (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2015-001923-22 | Sponsor Protocol Number: ADENOSINE-1 | Start Date*: 2015-12-16 |
| Sponsor Name:Amphia Ziekenhuis | ||
| Full Title: The effect of adenosine on myocardial protection in intermittent warm blood cardioplegia: a randomized placebo-controlled trial | ||
| Medical condition: Post-operative cardiac damage in patients scheduled for minimal invasive, port-access operations | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2014-005462-30 | Sponsor Protocol Number: MDCO-APO-14-01 | Start Date*: 2016-10-26 |
| Sponsor Name:The Medicines Company | ||
| Full Title: A multiple dose, dose-finding, placebo controlled, double blind, randomized trial to compare the effect of treatment on plaque burden as determined by intravascular ultrasound and evaluate the effi... | ||
| Medical condition: acute coronary syndrome | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: HU (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2015-000826-13 | Sponsor Protocol Number: MDCO-APO-15-01 | Start Date*: 2016-01-20 |
| Sponsor Name:The Medicines Company | ||
| Full Title: A placebo-controlled, double-blind, randomized trial to compare the effect of treatment on plaque burden as determined by intravascular ultrasound and to evaluate the efficacy, pharmacokinetics, sa... | ||
| Medical condition: acute coronary syndrome | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: CZ (Completed) HU (Completed) NL (Completed) PL (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2008-002708-25 | Sponsor Protocol Number: RIVAROXACS3001 (BAY59-7939/13194) | Start Date*: 2008-11-27 | |||||||||||
| Sponsor Name:Janssen-Cilag International N.V. | |||||||||||||
| Full Title: A Randomized, Double-Blind, Placebo-Controlled, Event-Driven Multicenter Study to Evaluate the Efficacy and Safety of Rivaroxaban in Subjects with a Recent Acute Coronary Syndrome The ATLAS ACS 2 ... | |||||||||||||
| Medical condition: Acute Coronary Syndrome (ACS) | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: SE (Completed) LT (Completed) DE (Completed) PT (Completed) SK (Completed) HU (Completed) FR (Completed) DK (Completed) GB (Completed) NL (Completed) ES (Completed) IT (Completed) LV (Completed) CZ (Completed) BG (Completed) BE (Prematurely Ended) GR (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2005-000412-27 | Sponsor Protocol Number: ARG-CS3-001 | Start Date*: 2005-08-22 |
| Sponsor Name:Arginox Pharmaceuticals, Inc. | ||
| Full Title: A Phase III International Multi-center, Prospective, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Nitric Oxide Synthase Inhibition with Tilarginine Acetat... | ||
| Medical condition: It is the intent of the proposed study to further evaluate the safety and efficacy of Tilarginine Acetate Injection as a novel, mortality reducing therapeutic drug for patients with cardiogenic sho... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: BE (Completed) DE (Prematurely Ended) HU (Prematurely Ended) AT (Completed) CZ (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2010-020497-41 | Sponsor Protocol Number: ANG.AMI-IC001 | Start Date*: 2013-02-13 | |||||||||||
| Sponsor Name:Mesoblast, Inc. | |||||||||||||
| Full Title: A prospective, double blind, randomized, placebo-controlled clinical trial of intracoronary infusion of immunoselected, bone marrow-derived Stro3 mesenchymal precursor cells (MPC) in the treatment ... | |||||||||||||
| Medical condition: ST-elevation myocardial infarction | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (GB - no longer in EU/EEA) BE (Completed) NL (Completed) DK (Completed) SE (Completed) CZ (Completed) AT (Prematurely Ended) PL (Completed) IT (Prematurely Ended) ES (Completed) PT (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2010-023779-24 | Sponsor Protocol Number: M10-1028 | Start Date*: 2010-12-06 |
| Sponsor Name:Stichting Toegepast Caridologisch Onderzoek | ||
| Full Title: A Comparison of Drug Eluting and Bare Metal Stents with Bivalirudin during PCI or Bivalirudin for 4 hours in Acute Coronary Syndromes. The Eindhoven Reperfusion Study | ||
| Medical condition: Patients with ACS who are scheduled for primary PCI (STEMI) or for immediate PCI < 2.5 hours or early PCI < 48 hours (NSTEMI) and who are pre-treated with HLD clopidogrel | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2021-005499-20 | Sponsor Protocol Number: RM21 | Start Date*: 2022-07-05 |
| Sponsor Name:Research Maatschap Cardiologen Rotterdam Zuid | ||
| Full Title: COMPARE STEMI ONE- Comparison Of reduced DAPT followed by P2Y12 inhibitor Monotherapy with Prasugrel vs stAndard Regimen in STEMI patients treated with OCT-guided vs aNgio-guided completE revascul... | ||
| Medical condition: ST elevated myocard infarction followed by PCI | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Trial now transitioned) DE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2005-001514-41 | Sponsor Protocol Number: G040188 | Start Date*: 2005-07-06 |
| Sponsor Name:The Cardiovascular Research Foundation | ||
| Full Title: A dual arm factorial randomized trial in patients with ST segment elevation AMI to compare the results of using either anticoagulation with unfractionated heparin plus routine GP IIb/IIIa inhibitio... | ||
| Medical condition: The medical condition for this clinical trial is Acute Myocardial Infarction (AMI). AMI is defined as death or necrosis of myocardial cells. It is a diagnosis at the end of the spectrum of myocardi... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: AT (Completed) SE (Prematurely Ended) ES (Completed) DE (Completed) GB (Completed) DK (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2013-000657-50 | Sponsor Protocol Number: PM1116197 | Start Date*: 2014-05-27 | ||||||||||||||||||||||||||
| Sponsor Name:GlaxoSmithKline Research & Development Ltd | ||||||||||||||||||||||||||||
| Full Title: A Clinical Outcomes Study to Compare the Incidence of Major Adverse Cardiovascular Events in Subjects Presenting with Acute Coronary Syndrome Treated with Losmapimod Compared to Placebo (PM1116197)... | ||||||||||||||||||||||||||||
| Medical condition: | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
| Trial protocol: SE (Completed) NL (Prematurely Ended) IT (Completed) DE (Completed) BE (Completed) SK (Completed) DK (Completed) ES (Completed) NO (Completed) GB (Completed) CZ (Completed) HU (Completed) EE (Completed) GR (Prematurely Ended) PL (Completed) BG (Completed) RO (Completed) | ||||||||||||||||||||||||||||
| Trial results: View results | ||||||||||||||||||||||||||||
| EudraCT Number: 2006-000658-27 | Sponsor Protocol Number: D5130C05262 | Start Date*: 2006-12-12 | |||||||||||
| Sponsor Name:AstraZeneca AB | |||||||||||||
| Full Title: A Randomised, Double-blind, Parallel Group, Phase 3, Efficacy and Safety Study of AZD6140 Compared with Clopidogrel for Prevention of Vascular Events in Patients with Non-ST or ST Elevation Acute C... | |||||||||||||
| Medical condition: non-ST and ST elevation acute coronary syndromes (ACS) | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (Completed) FI (Completed) PT (Completed) HU (Completed) DE (Completed) FR (Completed) SE (Completed) AT (Completed) NL (Completed) DK (Completed) SK (Completed) BE (Completed) CZ (Completed) GR (Completed) IT (Completed) ES (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
